Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Overview of attention for article published in BMC Cancer, February 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ERBB4 inhibitors and methods of use thereof

Grant US-10045990-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.